Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CLRB · NASDAQ · Pharmaceutical Preparations
$0.797−0.0859 (−9.73%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Cellectar Biosciences (CLRB) · oqro.io/stocks/CLRB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded May 7, 2026 · Filed May 12, 2026
CEO purchased ~$25K of CLRB shares in the open marketSourceInsider trade · Traded May 7, 2026 · Filed May 12, 2026
Officer purchased ~$25K of CLRB shares in the open marketSourceInsider trade · Traded Dec 12, 2025 · Filed Dec 16, 2025
Director sold ~$732 of CLRB shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
CEO purchased ~$50K of CLRB shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
CFO purchased ~$25K of CLRB shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
Officer purchased ~$50K of CLRB shares in the open marketSourceInsider trade · Traded Jan 10, 2025 · Filed Mar 13, 2025
Officer purchased ~$8.4K of CLRB shares in the open marketSource